Ellis Investment Partners’s Chemed CHE Stock Holding History

Ellis Investment Partners’s Portfolio CHE Stock Details CHE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-219	Closed	-$95K	–	289
2022 Q3	$95K	Hold	219	–	–	0.03%	303
2022 Q2	$102K	Hold	219	–	–	0.03%	301
2022 Q1	$110K	Hold	219	–	–	0.03%	299
2021 Q4	$115K	Hold	219	–	–	0.03%	295
2021 Q3	$101K	Hold	219	–	–	0.03%	304
2021 Q2	$103K	Hold	219	–	–	0.03%	294
2021 Q1	$101K	Hold	219	–	–	0.03%	290
2020 Q4	$117K	Hold	219	–	–	0.04%	260
2020 Q3	$105K	Hold	219	–	–	0.04%	256
2020 Q2	$100K	Hold	219	–	–	0.04%	257
2020 Q1	$87K	Hold	219	–	–	0.04%	216
2019 Q4	$96K	Hold	219	–	–	0.03%	243
2019 Q3	$90K	Hold	219	–	–	0.03%	244
2019 Q2	$79K	Buy	+219	New	+$73.2K	0.03%	266

Other funds holding CHE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ellis Investment Partners's CHE Position: Q4 2022 in Review

Ellis Investment Partners sold out of Chemed (CHE) in Q4 2022, closing a stake of 219 shares — an estimated $95K sold.

Ellis Investment Partners first reported a position in CHE in Q2 2019 and held it in 14 quarters. The position peaked at $117K in Q4 2020. 442 funds tracked by Wall St. Rank hold CHE as of Q4 2022.

Ellis Investment Partners reported no remaining Chemed position as of Q4 2022 after selling out during the quarter.
Ellis Investment Partners sold 219 Chemed shares in Q4 2022, an estimated $95K.
Ellis Investment Partners first reported a position in Chemed in Q2 2019 and held it in 14 quarters.
Ellis Investment Partners's Chemed position peaked at $117K in Q4 2020.
442 funds tracked by Wall St. Rank held Chemed as of Q4 2022.

Based on Ellis Investment Partners's 13F filing for Q4 2022, filed 31 Jan 2023.